Single-Use Negative Pressure Wound Therapy Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Wound Type (Ulcers, Surgical, Traumatic, Sports Injuries, Flaps and grafts, and Burns) and End User (Hospitals, Clinics, Ambulatory Surgica

Single-Use Negative Pressure Wound Therapy Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Wound Type (Ulcers, Surgical, Traumatic, Sports Injuries, Flaps and grafts, and Burns) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

The single-use negative pressure wound therapy devices market is projected to reach US$ 892.3 million by 2028 from US$ 498.3 million in 2021; it is estimated to grow at a CAGR of 8.8% during 2021–2028.

Increasing prevalence of wounds owing to various conditions—such as burns, trauma, surgery, and others—and rising demand for effective wound management are likely to fuel the market's growth.

Chronic diseases are illnesses that persist a year or longer and necessitate continuing medical attention, impede everyday activities or both. In the US, chronic diseases such as heart disease, cancer, and diabetes are the main causes of mortality and disability. The large patient pool in North America suffering from chronic diseases like diabetes has fueled the region's massive market expansion. Diabetic foot ulcers are common among diabetic patients. Furthermore, an increase in diabetic wounds in people is driving the demand for NPWT solutions. In the past few years, an increase in the frequency of chronic conditions such as obesity and type I and type II diabetes has fueled the demand for treatments involving negative pressure wound therapy devices, which has benefited the market growth. Simultaneously, increased patient awareness of the availability of low-cost NPWT devices such as single-use NPWT and a rise in the frequency of fatalities due to trauma and accidents have aided the expansion.

In 2019, a total of 8,378,122 new cases of burns were identified worldwide (95%, 10,363,109–6,531,887 cases). Burn fatality rates have been declining in many high-income nations, but child burn deaths are now approximately 7 times greater in low- and middle-income countries than in high-income countries. The single-use negative pressure wound therapy system is used to treat acute and chronic wounds and closed surgical incisions with low to moderate exudate levels. Negative pressure wound therapy (NPWT) involves applying negative pressure (a vacuum) to a wound to manage it and promote healing. Topical negative pressure (TNP) therapy, vacuum aided closure (VAC), and sealed surface wound suction are among the other names for NPWT. NPWT is used to help drain excess fluid and enhance localized blood flow in burn patients. It has been suggested that the action of NPWT may result in increased oxygen and nutrition being delivered to the burn, promoting healing. The single-use negative pressure wound therapy system is for individuals who would benefit from a suction device (negative pressure wound therapy), as it helps promote wound healing by removing low to moderate amounts of exudate and infectious debris. Chronic, acute, traumatic, subacute, and dehisced wounds; partial-thickness burns; ulcers (such as diabetic or pressure); flaps and grafts; closed surgical incisions are all examples of acceptable wound types.

Moreover, according to the Children's Burn Trust and the British Burn Association, 625 children are admitted to an NHS Burns Service each month owing to burn or scald injuries. In 2017, the NHS's burns and scalds services treated more than 15,000 patients with these injuries, with a total cost of more than US$ 24.94 million (i.e., GBP 20 million). More than 40 of the total burn treatment admissions in 2017 were classified as extremely serious, with treatment procedures costing more than US$ 118,455.50 (GBP 95,000) per person. Burns caused by home and industrial mishaps are rising in developing regions such as Asia Pacific, Africa, and the Middle East. Therefore, the market for single-use negative pressure wound care devices is being driven by an increase in the number of occurrences of burns and similar injuries.

COVID-19 placed a tremendous strain on healthcare systems globally. To decrease the risk of transmitting the virus to either patients or health care workers within their practice, providers postponed elective and preventive visits, such as annual physicals, and converted in-person visits to telemedicine visits whenever possible. However, the single-use negative pressure wound therapy devices market has observed a mixed impact due to the COVID-19 pandemic. Wound management is one of the high-demand areas in healthcare owing to the rising incidence of wounds globally. There has been a constant demand for single-use negative pressure wound therapy devices, which reduces the chances of contamination. The developed regions have seen a constant surge in demand for devices but developing and emerging countries from Asia Pacific and the Middle East & Africa have experienced a downfall due to the supply and demand gap created by the pandemic. With the successful rollout of vaccines in all regions, the volume of devices is beginning to recover with the restart of all healthcare services and wound clinics.

The global single-use negative pressure wound therapy devices market is segmented based on wound type and end user. The single-use negative pressure wound therapy devices market, based on wound type, is segmented into surgical, ulcers, traumatic burns, flaps & grafts, sports injury, and burns. The traumatic segment held the largest market share in 2021 and is anticipated to register the highest CAGR in the market during the forecast period due to the increasing number of accidents and trauma cases globally.

Based on end user, the single-use negative pressure wound therapy devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.

Australian Medical Association, European Wound Management Association, Nurses Specializing in Wound, Ostomy and Continence Canada, Japan Society for Surgical Wound Care, and Association for Burns Injuries Singapore are among the primary and secondary sources referred to while preparing the report on the single-use negative pressure wound therapy devices market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the single-use negative pressure wound therapy devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global single-use negative pressure wound therapy devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

The List of Companies - Single-Use Negative Pressure Wound Therapy Devices Market

1. Cardinal Health Inc
2. ConvaTec Group Plc
3. Carilex Medical
4. Genadyne Biotechnologies, Inc.
5. H and R Healthcare
6. Lohmann & Rauscher GmbH & Co. KG
7. Medela AG
8. Mölnlycke Health Care AB
9. Paul Hartmann Ag
10. Smith & Nephew plc